44 Wealth Management LLC Sells 732 Shares of Humana Inc. (NYSE:HUM)

44 Wealth Management LLC trimmed its position in shares of Humana Inc. (NYSE:HUM) by 30.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,671 shares of the insurance provider’s stock after selling 732 shares during the quarter. 44 Wealth Management LLC’s holdings in Humana were worth $424,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Deseret Mutual Benefit Administrators lifted its holdings in shares of Humana by 18.0% during the 4th quarter. Deseret Mutual Benefit Administrators now owns 399 shares of the insurance provider’s stock valued at $101,000 after buying an additional 61 shares during the period. Camelot Portfolios LLC bought a new position in shares of Humana during the 4th quarter valued at $574,000. Peregrine Asset Advisers Inc. bought a new position in Humana in the 4th quarter worth $4,327,000. Transcend Capital Advisors LLC raised its holdings in Humana by 399.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock worth $924,000 after purchasing an additional 2,914 shares during the period. Finally, Paradigm Asset Management Co. LLC raised its holdings in Humana by 766.7% in the 4th quarter. Paradigm Asset Management Co. LLC now owns 2,600 shares of the insurance provider’s stock worth $660,000 after purchasing an additional 2,300 shares during the period. 92.38% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of recent research reports. Piper Sandler raised their target price on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. TD Cowen raised their target price on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Wells Fargo & Company decreased their target price on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Finally, Bank of America raised Humana from an “underperform” rating to a “neutral” rating and raised their target price for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Humana has an average rating of “Hold” and a consensus price target of $285.68.

Humana Trading Down 5.7 %

HUM opened at $255.77 on Friday. The firm has a market cap of $30.80 billion, a P/E ratio of 25.71, a P/E/G ratio of 2.05 and a beta of 0.56. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a 50-day moving average of $269.41 and a 200 day moving average of $290.00.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.38%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s payout ratio is currently 35.58%.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.32% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.